US4804539A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Ophthalmic liposomes
Assignee: Liposome Technology Inc
•
Filing: 1986-07-28
•
Granted: 1989-02-14
•
Expires: 2006-07-28
Abstract
Abstract A liposome composition with enhanced retention on ocular surfaces, for use in ophthalmic drug delivery and dry eye treatment. The liposomes contain about 10-40 mole percent of an amine-derivatized lipid component in which a charged amine group is spaced from a lipid polar head region by a carbon-containing spacer arm at least 3 atoms in length. The liposomes preferably have a close packed lipid structure produced by inclusion of between 20-50 mole percent of cholesterol or an amine-derivatized cholesterol, and/or phospholipids with predominantly saturated acyl chain moieties. The liposomes may be suspended in an aqueous medium containing a high-viscosity polymer, formulated in paste form, or embedded in a polymer matrix, to enhance further the retention of liposomes on a corneal surface.
Inventors
- 👤 Luke S. S. Guo
- 👤 Carl T. Redmann
- 👤 Ramachandran Radhakrishnan
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 18:18
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/10; A61K9/127; Y; Y10; Y10S; Y10S436/00; Y10S436/829; Y10T; Y10T428/00; Y10T428/29; Y10T428/2982; Y10T428/2984
Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
119 words
A liposome composition designed for enhanced binding to ocular tissue, comprising liposomes, each having an outer lipid layer containing: (a) between about 40-80 mole percent of neutral vesicle forming lipid components selected from the group consisting of (a) neutral phospholipids and between 20-50 mole percent cholesterol and (b) neutral phospholipids with predominantly saturated acyl chains, and (b) between about 20-60 mole percent of positively-charged vesicle-forming lipid component(s) having (i) 2 aliphatic chains carried on a 3-4 carbon backbone, (ii) a polar atom attached to the backbone at a carbon atom which does not carry an aliphatic chain, (iii) an amine linked to the polar atom through a spacer at least 3 atoms long, and (iv) a net positive charge.
Claim 2
Dependent Claim
119 words
A liposome composition designed for enhanced binding to ocular tissue, comprising liposomes, each having an outer lipid layer containing: (a) between about 40-80 mole percent of neutral vesicle forming lipid components selected from the group consisting of (a) neutral phospholipids and between 20-50 mole percent cholesterol and (b) neutral phospholipids with predominantly saturated acyl chains, and (b) between about 20-60 mole percent of positively-charged vesicle-forming lipid component(s) having (i) 2 aliphatic chains carried on a 3-4 carbon backbone, (ii) a polar atom attached to the backbone at a carbon atom which does not carry an aliphatic chain, (iii) an amine linked to the polar atom through a spacer at least 3 atoms long, and (iv) a net positive charge.
Claim 3
Dependent Claim
43 words
The composition of claim 1, wherein the positively charged lipid component is a derivatized phospholipid of the form: ##STR2## where PE-NH 2 is phosphatidylethanolamine, and CO 2 -Y-NH 2 is a basic amino acid, or dipeptide containing at least one basic amino acid.
Claim 4
Dependent Claim
29 words
The composition of claim 2, wherein the basic amino acid or dipeptide is selected from the group consisting of lysine, arginine, histidine, ornithine, and dipeptides of these amino acids.
Claim 5
Dependent Claim
33 words
The composition of claim 1, which further includes a positively-charged cholesterol derivative having an amine group linked to the 6-membered cholesterol A ring by a carbon-containing spacer arm at least three atoms long.
Claim 6
Dependent Claim
29 words
The composition of claim 4, wherein the derivatized cholesterol has the form: Ch-O-C-Y-NH.sub.2, where Ch-OH is cholesterol and Y is a carbon-containing chain at least 2 atoms in length.
Claim 7
Dependent Claim
29 words
The composition of claim 4, wherein the derivatized cholesterol has the form: Ch-NH-Y-NH.sub.2, where Ch-NH 2 is cholesterol-3-amine, and Y is a carbon-containing chain at least two atoms long.
Claim 8
Dependent Claim
20 words
The composition of claim 1, wherein the amine-derivatized lipid component(s) are predominantly amine-derivatized phospholipids, and the liposomes contain 25-45% cholesterol.
Claim 9
Dependent Claim
22 words
The composition of claim 1, which further includes a high-viscosity polymer selected from the group consisting of hydroxyethylcellulose, hydroxypropylcellulose, polyvinylalcohol, and Neo-Tears™.
Claim 10
Dependent Claim
37 words
The composition of claim 1, for the treatment of dry eye, wherein the liposomes are suspended in an aqueous medium having a pH between about 6.2-6.8, and the lipid components making up the lipsosomes are substantially saturated.
Claim 11
Dependent Claim
28 words
The composition of claim 9, wherein the aqueous medium contains an iron and calcium chelator, in molar excess of the concentration of iron and calcium in the medium.
Claim 12
Dependent Claim
26 words
The composition of claim 9, wherein the liposomes are formulated to contain lipids selected from the group consisting of saturated cholesterol esters and long-chain fatty acid.
Claim 13
Dependent Claim
14 words
The composition of claim 9, wherein the liposomes are formulated to contain vitamin A.
Claim 14
Dependent Claim
30 words
The composition of claim 9, wherein the liposomes are suspended in an aqueous medium containing a polymer selected from the group consisting of hydroxyethylcellulose, hydroxypropylcellulose, methylcellulose, polyvinyl pyrrolidone, and polyvinylalcohol.
References Cited (Backward Citations)
US4229360A
Cited
US4229360B1
Cited
US4350676A
Cited
US4480041A
Cited
US4515736A
Cited
US4544545A
Cited
US4565696A
Cited
US4619913A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-02-14 | 1992-08-15 | 1993-02-14 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-02-14 | 1996-08-15 | 1997-02-14 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-02-14 | 2000-08-15 | 2001-02-14 | $7700.00 | Window Closed / Lapsed |